Trial intelligence / Profile preview

Epinephrine Addition to Spinal Bupivacaine for Repeat Cesarean Section

NCT02369510Phase 4Completed

Sponsor
Icahn School of Medicine at Mount Sinai
Start
Feb 2015
Primary completion
May 2016
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of epinephrine in cesarean section (3 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoint: Sensory Recovery up to 3 hours. Started Feb 2015; status: completed.

02

Drugs

epinephrine
03

Conditions

cesarean section

Beyond the preview

Go deeper on NCT02369510.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02369510.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call